GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,063 Cr | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr | ₹1,335 Cr |
What is the latest Profit Before Tax of GLAND PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹1,063 Cr |
| Mar2025 | ₹1,133 Cr |
| Mar2024 | ₹1,055 Cr |
| Mar2023 | ₹1,619 Cr |
| Mar2022 | ₹1,335 Cr |
How is Profit Before Tax of GLAND PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,063 Cr | -6.17 | |
| Mar2025 | ₹1,133 Cr | 7.39 | |
| Mar2024 | ₹1,055 Cr | -34.84 | |
| Mar2023 | ₹1,619 Cr | 21.26 | |
| Mar2022 | ₹1,335 Cr | - | |
Compare Profit Before Tax of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,414.4 Cr | -1.4% | 0.2% | 47.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.4% |
0.2% |
47.3% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses